Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Clinical trial NCT03050411 · UNKNOWN

Trial details

NCT number: NCT03050411
Sponsor: Peking University Third Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Nonsmall Cell Lung Cancer

Start date: 2016-05-01
Primary completion: 2019-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.